FDA Approves Epkinly (epcoritamab-bysp) Bispecific Antibody to Treat Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) NORTH CHICAGO, Ill., May 19, 2023 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp), as the first and only T-cell engaging bispecific antibody for the treatment of adult patients with […]

FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults PARSIPPANY, N.J., TEL AVIV & PARIS, April 28, 2023 – Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced today that the U.S. Food and Drug Administration (FDA) has approved Uzedy (risperidone) extended-release injectable suspension for […]

FDA Approves RizaFilm (rizatriptan) Oral Film for the Treatment of Acute Migraine SAINT LAURENT, Quebec, April 17, 2023 (GLOBE NEWSWIRE) — IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”), a leader in pharmaceutical films, today announced that the U.S. Food and Drug Administration (“FDA”) has approved the Company’s RizaFilm® VersaFilm® 505(b)(2) new drug application (NDA) for the treatment of acute migraine.1 […]

During the first two years of the covid-19 pandemic, while the federal government was trying to prevent people on Medicaid from losing health coverage, Idaho dropped nearly 10,000 people from the safety-net program. Federal law generally banned states from dropping people, and federal officials said Idaho acted improperly. Idaho officials, however, said they didn’t think they did anything wrong. The […]

California Attorney General Rob Bonta on Thursday sued the six major companies that dominate the U.S. insulin market, ratcheting up the state’s assault on a profitable industry for artificially jacking up prices and making the indispensable drug less accessible for diabetes patients.  The 47-page civil complaint alleges three pharmaceutical companies that control the insulin market — Eli Lilly and Co., […]

Antes de que comenzara la emergencia de salud pública por covid-19 en 2020, millones de niños entraban y salían de Medicaid cada año, un indicio de que muchos perdían la cobertura por problemas administrativos, y no porque sus familias ganaran más y ya no fueran elegibles. Ahora, varios estados del oeste del país, como California, buscan cambiar esta situación con […]

When President Joe Biden tested positive for covid-19 on July 21, his physician recommended he take the antiviral drug Paxlovid. The drug significantly reduces the likelihood of hospitalization or death for someone at high risk of developing severe covid. Biden started the five-day course that day, according to the White House, and within six days he tested negative for the […]

KHN senior correspondent Sarah Jane Tribble discussed her reporting for the podcast “Where It Hurts” on the “Too Long Didn’t Listen” podcast Feb. 3. Click here to hear Tribble on “Too Long Didn’t Listen“ Listen to “Where It Hurts“ KHN senior correspondent and enterprise reporter Liz Szabo discussed the problems immunocompromised people face in accessing a fourth covid-19 vaccine shot […]